Weekly paclitaxel combined with local hyperthermia in the therapy of breast cancer locally recurrent after mastectomy--a pilot experience

Onkologie
Z ZoulJ Petera

Abstract

The combination of chemotherapy and hyperthermia (HT) is a promising approach in the treatment of malignant tumors. In the present report we evaluate the efficacy and toxicity of a combination of weekly paclitaxel combined with local hyperthermia in breast cancer. 7 patients were treated for inoperable local recurrence of breast cancer after mastectomy, irradiation, and chemotherapy or hormonal therapy. They weekly received paclitaxel (60-80 mg/m(2)) in 3-h infusions followed by local HT 41-44 degrees C for 45 min for 6-18 cycles. Objective local response was observed in all treated patients (complete response in 4 patients and partial response in 3 patients). There were no grade 3 or 4 toxicities, neurologic toxicity or hypersensitivity reactions. Local tolerance to this regimen was also good, with only 4 patients developing mild transient erythema. Our experience indicates that the combination of weekly paclitaxel and HT may be effective in the treatment of locally recurrent breast cancer after mastectomy.

Citations

Apr 2, 2009·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Takayuki OhguriYukunori Korogi
Mar 27, 2013·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Tao HuangDianpeng Feng
Apr 17, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Tao HuangDian-Peng Feng
Jan 1, 2011·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Adam ChichełMarek Kanikowski
Feb 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Limor LandsmanSteffen Jung
Aug 18, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nobuaki MizutaniShin Yoshino
May 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alicia L HumlicekDwight C Look
Sep 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Harmjan KuipersBart N Lambrecht
Apr 2, 2019·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Mehmet Salih Iyikesici
Feb 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A G FrickD C Look
Sep 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Limor Landsman, Steffen Jung
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Monisha G ScottRobert E W Hancock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.